Greg Behar has served as Chief Executive Officer of Nestlé Health Science, a health sciences company, since October 2014.He currently serves on the board of directors of Aimmune Therapeutics, Inc. (Nasdaq: AIMT) and Seres Therapeutics, Inc. (Nasdaq: MCRB). Greg Behar holds an M.B.A. from INSEAD in France, a M.S. in mechanical engineering and manufacturing from EPFL in Switzerland, and a B.S. in mechanical engineering from the University of California, Los Angeles. We believe that Greg Behar’s extensive business experience in the health sciences and pharmaceutical industries qualifies him to serve on our board of directors.